dimethylformamide has been researched along with Prostatic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abedi, A; Amani, V; Bozorgmehr, M; Lighvan, ZM; Mirzadegan, E; Mohammadi, F; Safari, N; Shahsavar, F; Zarnani, AH | 1 |
Fayerweather, WE; Gilby, PG; Pell, S; Walrath, J | 1 |
2 other study(ies) available for dimethylformamide and Prostatic Neoplasms
Article | Year |
---|---|
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimethylformamide; DNA; Drug Resistance, Neoplasm; Epithelial Cells; Female; Humans; Intercalating Agents; Male; MCF-7 Cells; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Prostatic Neoplasms; Spectrophotometry | 2016 |
A case-control study of cancer among du pont employees with potential for exposure to dimethylformamide.
Topics: Adult; Aged; Chemical Industry; Cohort Studies; Dimethylformamide; Evaluation Studies as Topic; Facial Neoplasms; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Occupational Diseases; Pharyngeal Neoplasms; Prostatic Neoplasms; Regression Analysis; Risk Factors; Sampling Studies; Skin Neoplasms; Testicular Neoplasms; Time Factors | 1989 |